ONESOURCE Stock Overview

A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of biological drug products in various injectable formats in India and internationally. More details

ONESOURCE fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	1/6
Dividends	0/6

Rewards

Revenue grew by 686.8% over the past year

Risk Analysis

Shares are highly illiquid

Less than 3 years of financial data is available

My Notes

Capture your thoughts, links and company narrative

OneSource Specialty Pharma Limited Competitors

Biocon

NSEI:BIOCON

₹433.9b

Panacea Biotec

NSEI:PANACEABIO

₹20.9b

Hester Biosciences

BSE:524669

₹16.7b

Zenotech Laboratories

BSE:532039

₹3.7b

Price History & Performance

Summary of share price highs, lows and changes for OneSource Specialty Pharma
Historical stock prices
Current Share Price	₹1,581.50
52 Week High	₹1,800.00
52 Week Low	₹1,466.15
Beta	0
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-7.51%

Recent updates

Shareholder Returns

	ONESOURCE	IN Biotechs	IN Market
7D	-7.5%	-10.1%	-1.8%
1Y	n/a	33.1%	6.2%

Return vs Industry: Insufficient data to determine how ONESOURCE performed against the Indian Biotechs industry.

Return vs Market: Insufficient data to determine how ONESOURCE performed against the Indian Market.

Price Volatility

Is ONESOURCE's price volatile compared to industry and market?
ONESOURCE volatility
ONESOURCE Average Weekly Movement	n/a
Biotechs Industry Average Movement	6.3%
Market Average Movement	6.3%
10% most volatile stocks in IN Market	9.1%
10% least volatile stocks in IN Market	4.3%

Stable Share Price: ONESOURCE's share price has been volatile over the past 3 months compared to the Indian market.

Volatility Over Time: Insufficient data to determine ONESOURCE's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2007	1,250	Neeraj Sharma	www.onesourcecdmo.com

OneSource Specialty Pharma Limited, a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of biological drug products in various injectable formats in India and internationally. The company provides end-to-end CDMO services across various phases of preclinical and clinical development and commercial supply of biologics. It also offers drug-devices, including prefilled syringes, dial and push variable and fixed dose pen injectors, pull push fixed dose pens, and autoinjectors; sterile injectables; soft gelatin capsules; and biologics solutions for microbial and mammalian cell line biopharmaceuticals, cell and gene therapy, and RNA products.

OneSource Specialty Pharma Limited Fundamentals Summary

How do OneSource Specialty Pharma's earnings and revenue compare to its market cap?
ONESOURCE fundamental statistics
Market cap	₹180.98b
Earnings (TTM)	-₹1.57b
Revenue (TTM)	₹10.92b

16.6x

P/S Ratio

-115.5x

P/E Ratio

Is ONESOURCE overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ONESOURCE income statement (TTM)
Revenue	₹10.92b
Cost of Revenue	₹3.58b
Gross Profit	₹7.34b
Other Expenses	₹8.91b
Earnings	-₹1.57b

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	-13.69
Gross Margin	67.26%
Net Profit Margin	-14.34%
Debt/Equity Ratio	30.4%

How did ONESOURCE perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/31 18:22
End of Day Share Price	2025/01/31 00:00
Earnings	2024/12/31
Annual Earnings	2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

OneSource Specialty Pharma Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution

OneSource Specialty Pharma NSEI:ONESOURCE Stock Report